FeaturedNeurologyOpen Neuroscience Articles·January 9, 2017·5 min readBreakthrough in Multiple Sclerosis TreatmentClinical trials show that a new drug called ocrelizumab can reduce attacks in people with RRMS, and can reduce new symptom development in patients with primary progressive multiple sclerosis.Read More